| 
 | |||||
|   | 
| 
 | 

Regional banking company Trustmark (NASDAQ:TRMK) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 5.3% year on year to $202.4 million. Its non-GAAP profit of $0.94 per share was in line with analysts’ consensus estimates.
Is now the time to buy TRMK? Find out in our full research report (it’s free for active Edge members).
Trustmark’s third quarter results drew a negative market reaction, as higher-than-expected expenses and competitive deposit dynamics weighed on sentiment. Management attributed performance to steady loan growth across commercial and real estate segments, as well as successful deposit gathering in key markets. CEO Duane Dewey emphasized, “Our performance reflected diversified loan growth and stable credit quality, along with cost-effective core deposit growth.” Trustmark also faced increased noninterest expenses, partly due to strategic hiring and nonroutine items like professional fees and reserves. The quarter’s focus centered on expanding production talent to support organic growth strategies, especially in competitive metropolitan areas.
Looking ahead, Trustmark’s guidance is underpinned by expectations of mid-single-digit loan growth and stable credit quality, though management remains cautious about short-term expense pressure from recent hiring activity. Dewey noted that the company is investing in “key growth markets” and anticipates these additions will drive revenue expansion, while CFO Tom Owens cautioned that net interest margin could see some volatility as the bank responds to potential Federal Reserve rate cuts. The company will continue balancing capital deployment between organic growth, opportunistic share repurchases, and monitoring M&A developments in its core regions.
Management highlighted the impact of organic hiring, deposit competition, and shifting loan yields on the quarter’s operating performance, while outlining progress in targeted market expansion.
Management’s outlook centers on organic loan and deposit growth, expense discipline, and navigating a competitive deposit landscape influenced by interest rate changes.
Going forward, our analysts will track (1) Trustmark’s ability to translate new hires into sustainable loan and deposit growth in core markets, (2) the bank’s effectiveness in maintaining net interest margin stability as the Federal Reserve adjusts rates, and (3) progress in expense containment relative to revenue expansion. We will also monitor any strategic shifts in capital deployment, particularly as M&A opportunities emerge in Trustmark’s footprint.
Trustmark currently trades at $38.42, in line with $38.64 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-30 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-26 | |
| Oct-23 | |
| Oct-05 | |
| Oct-01 | |
| Sep-30 | |
| Sep-11 | 
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite